Treatment of inflammatory diseases by inhibiting cold-inducible RNA-binding protein (CIRP)
US9109023B2 · kind B2 · utility
3Cited by
2References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 4, 2014 |
| Grant date | Aug 18, 2015 |
| Priority date | — |
| Expiry date | Mar 4, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are pharmaceutical compositions comprising a CIRP inhibitor. A method of treating a subject suffering from an inflammatory condition comprising administering to said subject a CIRP inhibitor is also described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.